Invivoscribe also offers comprehensive MyAML ®, MyHeme ®, MyMRD ®, and
custom gene panels, that when used in combination with Invivoscribe's proprietary MyInformatics ® Software can identify and track primary driver mutations as well as the subclonal architecture and emergence of new driver mutations in patients with hematologic disease.
Invivoscribe's clinical laboratories also offer comprehensive MyAML ®, MyHeme ®, MyMRD ®, and
custom gene panels, that when used in combination with Invivoscribe's proprietary MyInformatics ® Software can identify and track primary driver mutations as well as the subclonal architecture and emergence of new driver mutations in patients with hematologic disease.
Invivoscribe also offers comprehensive MyAML ®, MyHEME ®, MyMRD ®, and
custom gene panel services.
Not exact matches
Importantly, this requires a separate assay: usually, a
custom array with oligos designed for each exon in every
panel gene.